I believe that as soon as they publish some results of the BTT...

I believe that as soon as they publish some results of the BTT trials, and they are in the same vacinity as the earlier trials with respect to efficacy, and before getting FDA approval, you should see the sp appreciate.

This will be due to other companies wanting to get a slice of the action. Once the sp starts to appreciate (because someone is buying it), it will show up on the radar of instos and traders. This should cause the sp to appreciate more.

IMO, the crunch will come when someone announces a take-over, as by then, getting FDA approval will almost (and I emphasise almost) a rubber stamp (if throatec can get it with its device and efficacy......).

The only question is, how much will they offer?? Because this will provide some hint as to how long they believe the technology is good for!!!

On the basis of 2 enrolments per week (from May 6 (57) to June 16 (70), 13 people were enrolled in BTT), this means that to complete enrolment for BTT they need 140-70= 70 / 2 = 35 weeks (Mid Feb 2009).

Mind you, I am assuming that enrolment is the same as the implantating. Clearly when VCR uses the word enrolment it is a mixture of enrolment and implantation statistics.

If they publish early results as they stated in the last press release, then may be around Nov/Dec we should be seeing some movement in the sp!!

I just can not believe that a company with a device like this, and as advanced in the trials as this, is NOT ALREADY on the radar of other companies!!!! Particularly with a SH&^y sp and an even SH&^ier management team.

I believe (IMO) sh will be so glad to get an offer, any offer to off-load their non-performing shares and get rid of a SH&^y management team, that they will jump at it!!!!

This is just my opinion, and not an advice or analysis. Please do your own research.